Drugs News and Research

RSS

Babies experiencing hypoxia due to sleep apnea tend to develop hypertension in adulthood

Newborn babies who experience low levels of oxygen in their body tissues (hypoxia) due to sleep apnea, for example, tend to develop respiratory problems and hypertension (high blood pressure) in adulthood, and these problems may persist for the rest of their lives.

31 May 2023

The immunopathology of post-acute sequelae of SARS-CoV-2 infection: highlighting the knowledge gaps

The immunopathology of post-acute sequelae of SARS-CoV-2 infection (PASC).

31 May 2023

Biomarker study reveals the effects of astrocyte reactivity in preclinical Alzheimer's disease

Evidence supports a close link between Aβ, astrocyte reactivity, and tau pathology in preclinical AD.

31 May 2023

Red alert on energy drinks: Severe health risks for kids and teens

Research investigates the adverse health effects associated with energy drink consumption in children and adolescents. The study highlights the impact on different organ systems, the role of trigger factors, and the presence of preexisting health conditions.

30 May 2023

Largest clinical case series of laughing gas users finds a predominance of young Asian men

The largest clinical case series to date of recreational users of nitrous oxide, popularly known as laughing gas, has found a predominance of young men of Asian ethnicity among those with neurological side effects who were seen at hospitals in 3 major cities in England.

30 May 2023

$Study shows ketamine nasal spray as a safe and effective treatment for refractory migraine$

Study shows ketamine nasal spray as a safe and effective treatment for refractory migraine

Ketamine taken in the form of a nasal spray may prove a safe and effective treatment for refractory chronic migraine, suggests a single centre study, published in the open access journal Regional Anesthesia & Pain Medicine.

30 May 2023

Extended lymphadenectomy for locally advanced bladder cancer provides no patient benefit

An extended lymphadenectomy – removal of additional lymph nodes beyond the extent of the standard procedure – in patients undergoing radical cystectomy (removal of bladder and nearby tissues) because of clinically localized muscle-invasive bladder cancer provides no patient benefit as measured by disease-free survival or overall survival times.

30 May 2023

Experimental decoy provides long-term protection from SARS-Cov-2 infection

An experimental "decoy" provided long-term protection from infection by the pandemic virus in mice, a new study finds.

30 May 2023

Using generative AI to accelerate the drug development process

While it can take years for the pharmaceutical industry to create medicines capable of treating or curing human disease, a new study suggests that using generative artificial intelligence could vastly accelerate the drug-development process.

30 May 2023

Mutated gene protects the kidney from hypertension-induced damage

A mutation that causes severe hypertension also protects the kidneys from being damaged, reports a team led by Enno Klußmann of the Max Delbrück Center and the DZHK in "Kidney International".

30 May 2023

Innovative probe could deepen our understanding of crucial cellular messenger and pave way for new therapeutic drugs

A ground-breaking study by Loughborough University and the University of Oxford has led to the development of a small molecule probe that could deepen our understanding of a crucial cellular messenger and lead to the development of new therapeutic drugs.

30 May 2023

Treatment with modified lactic acid bacteria accelerates the healing of wounds, study shows

Complicated, hard-to-heal wounds are a growing medical problem and there are currently only two drugs approved with proven efficacy.

30 May 2023

INTEGRA’s PIPETBOY Makes Pipetting Easy for Molecular Biology Techniques

INTEGRA Biosciences’ PIPETBOY acu 2 pipette controller is helping researchers in the Immune Sensing and Signaling Dynamics group/ImmunoHUB at the i3S in Porto, Portugal, to further their research into the role of the aryl hydrocarbon receptor (AHR) in infection and cancer.

From INTEGRA Biosciences 30 May 2023

Stimulating a bile acid receptor can help protect the vision of premature newborns

It sounds like bile acid in the eye would hurt, but scientists think stimulating one of its receptors can actually help protect the vision of premature newborns.

30 May 2023

Novel assay for identifying individuals with synucleinopathies using serum samples

Synucleinopathies are a group of neurodegenerative diseases caused by the abnormal accumulation α-synuclein, a protein normally found in the brain and neurons. Incorrect folding of α-synuclein leads to formation of 'seeds', which attract more α-synuclein proteins to form larger clumps.

29 May 2023

Two key physiological systems found to be involved in high-salt-induced hypertension and dementia

Dementia is defined as the loss of cognitive functioning - including thinking, remembering, and reasoning - and is very prevalent in Japan.

29 May 2023

New understanding of chemotherapeutic resistance in recurring ovarian cancer

A new editorial paper was published in Oncoscience (Volume 10) on May 11, 2023, entitled, "UPR-induced ovarian cancer cell fusion: a mechanism favoring drug resistance?"

26 May 2023

Study identifies a novel druggable signaling molecule involved in obesity and diabetes

More than 40% of Americans are considered obese, and the trend continues to grow. The treatments or preventive options for obesity and obesity-associated diseases are limited.

26 May 2023

Phase 3 studies for rectal, brain, and kidney cancers to be presented by Dana-Farber researchers at ASCO 2023

Several phase 3 studies conducted by researchers from Dana-Farber Cancer Institute show promising results for patients with rectal, brain, and kidney cancers. The results of these studies, along with dozens of others led by Dana-Farber researchers, will be presented at the 2023 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago.

26 May 2023

Sacubitril/valsartan and dapagliflozin combination exerts better effects in patients with diabetes and STEMI

Announcing a new article publication for Cardiovascular Innovations and Applications journal. This study was aimed at observing the clinical effects of sacubitril/valsartan combined with dapagliflozin on cardiac function and ventricular remodeling in patients with type 2 diabetes and ST-segment elevation myocardial infarction (STEMI).

26 May 2023

Drugs News and Research

Babies experiencing hypoxia due to sleep apnea tend to develop hypertension in adulthood

The immunopathology of post-acute sequelae of SARS-CoV-2 infection: highlighting the knowledge gaps

Biomarker study reveals the effects of astrocyte reactivity in preclinical Alzheimer's disease

Red alert on energy drinks: Severe health risks for kids and teens

Largest clinical case series of laughing gas users finds a predominance of young Asian men

Study shows ketamine nasal spray as a safe and effective treatment for refractory migraine

Extended lymphadenectomy for locally advanced bladder cancer provides no patient benefit

Experimental decoy provides long-term protection from SARS-Cov-2 infection

Using generative AI to accelerate the drug development process

Mutated gene protects the kidney from hypertension-induced damage

Innovative probe could deepen our understanding of crucial cellular messenger and pave way for new therapeutic drugs

Treatment with modified lactic acid bacteria accelerates the healing of wounds, study shows

INTEGRA’s PIPETBOY Makes Pipetting Easy for Molecular Biology Techniques

Stimulating a bile acid receptor can help protect the vision of premature newborns

Novel assay for identifying individuals with synucleinopathies using serum samples

Two key physiological systems found to be involved in high-salt-induced hypertension and dementia

New understanding of chemotherapeutic resistance in recurring ovarian cancer

Study identifies a novel druggable signaling molecule involved in obesity and diabetes

Phase 3 studies for rectal, brain, and kidney cancers to be presented by Dana-Farber researchers at ASCO 2023

Sacubitril/valsartan and dapagliflozin combination exerts better effects in patients with diabetes and STEMI

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News